VRTX CIK: 875320

Vertex Pharmaceuticals Incorporated

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.64
FY22:
4.13
FY23:
3.54
FY24:
−0.49
FY25:
3.63
Change from FY21 to FY25
billions USD
FY21:
−0.34
FY22:
−0.32
FY23:
−3.14
FY24:
−3.77
FY25:
−0.95
Change from FY21 to FY25
billions USD
FY21:
−1.48
FY22:
−0.07
FY23:
−0.56
FY24:
−1.49
FY25:
−2.26
billions USD
FY21:
0.81
FY22:
3.71
FY23:
−0.14
FY24:
−5.80
FY25:
0.52
(positive)
Change from FY21 to FY25
billions USD
FY21:
2.41
FY22:
3.93
FY23:
3.34
FY24:
−0.79
FY25:
3.19

All amounts in billions USD Data source:SEC EDGAR